
X
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
https://pharmaphorum.com/news/roche-blueprint-raise-pressure-on-lilly-with-new-gavreto-approval/
Eisai’s drug finally funded after two year delay
Thyroid cancer drugs are available in Scotland and Wales
NICE unconvinced by survival data from Ipsen and Sanofi drugs
Japanese firm has set money aside for emerging markets M&A.
Lenvima available in Scotland, not England.
Thyroid cancer drug falls through gap in NHS funding